HCA Healthcare, Inc.
NYSE:HCAMedical - Care Facilities
-$12.05 today
- Market cap
- $99.51B
- Beta
- 1.13
- P/E (TTM)
- 12.5
- EPS (TTM)
- $29.98
- Dividend yield
- 0.80%
Volume 1.60M
Average 1.37M
HCA Net Income
Bottom-line profit, the starting point for calculating cash from operations.
HCA Healthcare, Inc.NYSE: HCA
Net Income · Q2 FY2026 · quarter ended Jun 2026
Net income dips below year-ago levels
Q2 FY2026 net income of $1.7B fell 10.2% year over year, behind the +3.1% change in trailing-twelve-month net income. Sequentially, it rose 4.9% from the prior quarter. Over 3 fiscal years it compounded at -0.2% a year.
Context
- Net income amounted to 9.0% of revenue in FY2025, down 0.5 pp from a year earlier.
- Net income increased in 2 of the last 3 fiscal years.
What to watch
Whether net income reaches the consensus estimate from 18 analysts of $6.89B (+1.6%) for the fiscal year ending Dec 2026, a pace similar to FY2025.
Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- $1.7B+4.9% QoQ
- Last fiscal yearDec 2025
- $6.78B+1.9% YoY
- LTMJun 2026
- $6.84B+3.1% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -10.2% | -12.0% | -1.9 pp |
| 1 year | +1.9% | +1.6% | -0.3 pp |
| 3-year CAGR | -0.2% | +6.0% | +6.2 pp |
| 5-year CAGR | +8.7% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Income history
USD · from the cash flow
- Latest · FY2025
- 6.78B USD
- Year-over-year change
- +1.9%
- 4-year CAGR
- -3.2%
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 6.78B | +1.9% |
| FY2024 | 2024-12-31 | 6.66B | +27.0% |
| FY2023 | 2023-12-31 | 5.24B | -23.3% |
| FY2022 | 2022-12-31 | 6.83B | -11.5% |
| FY2021 | 2021-12-31 | 7.72B | — |
Net Income vs competitors
How HCA compares with its peers on the latest reported figures
- HCA's LTM Jun 2026 net income of $6.84B is the largest of the 6 companies compared; the peer median is $497M.
- Its year-over-year change of +3.1% is the 5th highest of 6, against a peer median of +19.5%.
- Net income amounts to 8.8% of revenue for HCA, versus a peer median of 4.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $6.84B | +3.1% | -0.2% | 8.8% | |
| LTM Jun 2026 | $2.68B | +11.9% | +12.0% | 12.3% | |
| LTM Jun 2026 | $1.53B | +19.5% | +32.0% | 8.4% | |
| LTM Mar 2026 | $497M | +202.1% | +144.9% | 2.3% | |
| LTM Jun 2026 | $269.13M | +104.3% | +8.4% | 4.8% | |
ARDTArdent Health Partners, LLC | LTM Mar 2026 | $186.34M | -23.1% | -4.6% | 2.9% |
| Peer median (excluding HCA) | $497M | +19.5% | +12.0% | 4.8% | |
Competitors are the stored peer set for HCA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 7.72B | 6.83B | 5.24B | 6.66B | 6.78B |
| Depreciation & Amortization | 2.85B | 2.97B | 3.08B | 3.31B | 3.52B |
| Deferred Income Tax | (70M) | 571M | 229M | 22M | 0 |
| Stock-Based Compensation | 440M | 341M | 0 | 360M | 0 |
| Change in Working Capital | (503M) | (1.15B) | (457M) | (106M) | 728M |
| Accounts Receivables | (962M) | (797M) | (935M) | (799M) | (94M) |
| Inventory | (540M) | (59M) | (126M) | 334M | (154M) |
| Accounts Payables | 999M | (296M) | 604M | 359M | 666M |
| Other Working Capital | 0 | 0 | 0 | 0 | 310M |
| Other Non-Cash Items | (1.48B) | (1.04B) | 1.34B | 269M | 1.6B |
| Operating Cash Flow | 8.96B | 8.52B | 9.43B | 10.51B | 12.64B |
| Capital Expenditures | (3.58B) | (4.4B) | (4.74B) | (4.88B) | (4.94B) |
| Acquisitions (Net) | 1.06B | 1.01B | (442M) | 62M | (128M) |
| Purchases of Investments | (117M) | (14M) | 0 | 0 | 0 |
| Sales of Investments | 117M | 14M | 0 | 0 | 72M |
| Other Investing Activities | (121M) | (7M) | (131M) | (120M) | 12M |
| Investing Cash Flow | (2.64B) | (3.39B) | (5.32B) | (4.93B) | (4.99B) |
| Debt Repayment | 3.26B | 3.29B | 1.3B | 3.21B | 3.21B |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (8.22B) | (7B) | (3.81B) | (6.04B) | (10.07B) |
| Dividends Paid | (624M) | (653M) | (661M) | (690M) | (679M) |
| Other Financing Activities | (1.07B) | (1.29B) | (917M) | (1.06B) | (1.01B) |
| Financing Cash Flow | (6.66B) | (5.66B) | (4.09B) | (4.58B) | (8.55B) |
| Effect of Forex Changes | (3M) | (20M) | 7M | (1M) | 9M |
| Net Change in Cash | (342M) | (543M) | 27M | 998M | (893M) |
| Free Cash Flow | 5.38B | 4.13B | 4.69B | 5.64B | 7.69B |
HCA Healthcare, Inc.
NYSE:HCA
Intrinsic Alpha fair value
Locked
Current Price
$476.35
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.